Switzerland · Series B startup
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$33Mraised across 2 rounds since 2014, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
This firm lists Amal Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Amal Therapeutics's investors include Boehringer Ingelheim Venture Fund, Venture Kick, High-Tech Gruenderfonds, HTGF High-Tech Gründerfonds and VI Partners, and 1 more on record.
Amal Therapeutics has raised $33M across 2 rounds since 2014. One round did not disclose an amount, so the total is a floor.
Amal Therapeutics's most recent round was a Series B of $33M in Nov 2018.
Its most recent round, $33M in Nov 2018, is also its largest on record.
Amal Therapeutics's first round on record, in Feb 2014, was backed by High-Tech Gruenderfonds and Boehringer Ingelheim Venture Fund.
Amal Therapeutics's latest named round is a Series B, in Nov 2018.
Amal Therapeutics is based in Switzerland.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Switzerland · 
